Fate Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$1.13(as of Jul 15, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Fate Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.13
Ticker SymbolFATE
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees181
CountyUSA
Market Cap$130.7M
EBIDTA-168.3M
10-Day Moving Average1.13
P/E Ratio-0.76
20-Day Moving Average1.14
Forward P/E Ratio0.00
50-Day Moving Average1.20
Earnings per Share-1.49
200-Day Moving Average1.66
Profit Margin-2,309.45%
RSI46.20
Shares Outstanding114.6M
ATR0.10
52-Week High5.92
Volume946,473
52-Week Low0.66
Most Recent Support Level1.12
Book Value288.4M
Most Recent Resistance Level1.18
P/B Ratio0.46
Upper Keltner1.36
P/S Ratio10.03
Lower Keltner0.92
Debt-to-Equity Ratio1.36
Next Earnings Date07/30/2025
Cash Surplus16.8M
Next Ex-Dividend DateUnknown

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Fate Therapeutics Inc In Our Stock Scanner

example chart graphic
Date: Jul 16, 2025Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 16, 2025Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 16, 2025Scan Name: Downtrending StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 16, 2025Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 16, 2025Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.